LATEST UPDATES » Big Data, Bigger Disease Management and Current preparations to manage the Future Health of Singaporeans       » Big Data in Clinical Research Sector       » Professor Yuk-ling Yung receives Gerard P. Kuiper Prize       » AXA Assistance on Regenerative Medicine       » Singtel – Singapore Cancer Society Race against Cancer 2015       » Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death      
Yingli Green Energy enters joint venture with Datong Coal Mine Group
Yingli Energy (China) Company Limited, a subsidiary of Yingli Green Energy, the world's largest vertically integrated photovoltaic (PV) module manufacturer, has entered an agreement to establish a joint venture with Shuozhou Coal Power Co., Ltd., a subsidiary of Datong Coal Mine Group Co., Ltd., which is China's third largest state-owned coal mining enterprise. The joint venture will develop and construct solar power plants in Shuozhou city, Shanxi province.

The joint venture is a sign of Yingli China and Datong Coal Mine Group's strong partnership. Previously, the two companies cooperated on a 20 MW utility-scale project located in Shanxi Province's Tashan circular economic park, in which Yingli China served as both module supplier and EPC.

"We are very pleased to deepen our strategic partnership with Yingli Green Energy, a worldwide PV industry leader. Our joint venture echoes the national target for the building of a beautiful China and will help to meet our national targets for clean electricity generation. Additionally, the joint venture is in line with the strategy of Datong Coal Mine Group's sustainable development," commented Mr. Chengsheng Li, the Chairman of the Joint Venture and Shuozhou Coal Power.

"We are delighted to enhance the cooperation with Datong Coal Mine Group through our new joint venture," said Mr. Liansheng Miao, Chairman and Chief Executive Officer of Yingli Green Energy. "This partnership provides Yingli Solar with a strategic avenue to expand our domestic downstream business. By leveraging advantages of both companies, we will be able to accelerate the project development and bring significant benefits to all parties involved."

Source: PR Newswire

Click here for the complete issue.

news Runners' High, Happy Feet — If you're Happy, and you know it 'Clap' your Feet
news Snapshot of Stem Cell Expression using Single-cell RNA Sequencing
news A Heroic Voyage — Sydney Brenner's Life in Science
news VeloX, A Minimally Invasive Prosthetic Heart Valve for treating Mitral Regurgitation
news Anti-CD25 monoclonal antibody (90Y-daclizumab) a favorable target towards systemic radio-immunotherapy in Hodgkin's Lymphoma

Credits to Sony Computer Entertainment and click here for behind the scenes.

APBN Editorial Calendar 2015
Trends and Predictions for 2015 Robotics in Healthcare Nutrition Universal Health Coverage
Start-Up Biotech Companies Preventative and Translational Medicine Biofuels ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development Antibody Engineering in Japan Christmas Edition
APBN Editorial Calendar 2016
Korea's Biotechnology Industry Nutrition and Allergies: Are we, Too Clean? Medical Devices and Technology: Innovation that leaves an Inspiration Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine Occupational Health Water Technology Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy